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The effect of nitroglycerine on some parameters of the prooxidant-antioxidant balance
and functional state of the liver under conditions of ischemia/reperfusion was studied
on rabbits. Hepatic ischemia/reperfusion was accompanied by accumulation of LPO
products, depletion of the antioxidant defense system, and increase in blood trans-
aminase activity. Nitroglycerine infusion before the reperfusion period decreased the
concentration of LPO products, increased activity of the antioxidant system, and impro-
ved liver function.
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Liver ischemia/reperfusion often accompanies re-
sections and transplantations of this organ and hemor-
rhagic shock followed by blood transfusion [3,4].
The pathogenetic mechanisms of this syndrome
include oxidative stress, inflammatory reaction and
migration of leukocytes to the parenchyma, and
microcirculatory disturbances. These disorders re-
sult in hepatocyte necrosis or apoptosis [2]. Insuf-
ficient production of nitric oxide (NO) and predo-
minance of endothelins contribute to microcircula-
tory disturbances in the liver during reperfusion
[1,8]. It should be emphasized that NO in high
concentration has cytotoxic effect on hepatocytes.
The necessity of maintaining the balance between
the damaging and protective effects of NO requires
the development of new methods for correction of
postischemic liver injury.
Here we studied the effect of nitroglycerine
(NG) on the prooxidant-antioxidant balance and
function state of the liver during ischemia/reper-
fusion.
MATERIALS AND METHODS
Experiments were performed on adult male rabbits
weighing 3.5-4.5 kg and maintained in a vivarium
under standard conditions. The animals were anes-
thetized by intravenous infusion of calipsol (1.5
mg/kg/min). Hepatic ischemia was induced by 30-
min clamping of a. hepatic propria. The reperfusion
period was 120 min. A catheter was introduced into
v. hepatica to obtain hepatic venous blood. Another
catheter was inserted into the right atrium to take mixed
venous blood samples. Blood samples were with-
drawn before, by the end, and 120 min after ischemia
to study LPO products and activity of the antioxidant
system. Liver tissue was taken by the end of reper-
fusion to evaluate the prooxidant-antioxidant state.
Liver samples obtained before ischemia (n=6) served
as the control. The degree of liver injury was estima-
ted by measuring plasma alanine aminotransferase
(ALT) and aspartate aminotransferase (AST) activities.
The animals were divided into 2 groups. Liver
ischemia/reperfusion was induced in group 1 rab-
bits (n=10). Group 2 animals (n=8) with hepatic
ischemia/reperfusion received intravenous infusion
of NG (1.5 µg/kg) 5 min before the reperfusion
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period [10]. The total concentration of nitrites and
nitrates in blood plasma was measured using Griess
reagent [6]. Cadmium was used for reduction of
nitrates to nitrites.
The concentrations of conjugated dienes (CD),
Schiff bases (SB), and α-tocopherol and activity of
catalase reflected the prooxidant-antioxidant balan-
ce. CD concentration in biological materials was
measured by UV spectrophotometry at 233 nm [5].
SB concentration was estimated from fluorescence
of the chloroform extract on an F-4010 spectrofluo-
rometer (Hitachi) at excitation and emission wave-
lengths of 344 and 440 nm, respectively. α-Toco-
pherol concentration was measured fluorometri-
cally by recording fluorescence of hexane extracts
[5]. α-Tocopherol from Sigma served as the con-
trol. Catalase activity in biological materials was
measured by the spectrophotometric method based
on the ability of H2O2 to react with molybdenum
salts with the formation of a stable colored
complex [5].
The results were analyzed by Student’s t test.
RESULTS
CD concentration in the plasma of hepatic venous
blood from group 1 animals was 267.2% higher
compared to the basal level (p<0.05). SB concentra-
tion in the plasma of hepatic venous blood increa-
sed by 69% by the end of reperfusion (p<0.05). The
concentrations of CD and SB in the blood from
group 2 rabbits increased less significantly (Table
1). CD concentration in the plasma of hepatic ve-
nous blood taken by the end of reperfusion was
57.6% higher compared to the basal level (p<0.05).
SB concentration in the plasma of hepatic venous
blood exceeded the basal level only by the end of
ischemia (by 21.4%, p<0.05).
Activity of the antioxidant defense system de-
creased during experimental ischemia/reperfusion
(Table 1). By the 30th minute of ischemia, α-toco-
pherol concentration in the plasma of hepatic ve-
nous blood was 93% of the basal level (p<0.05).
α-Tocopherol concentration in the plasma of mixed
venous blood decreased to 75.4% by the 120th
minute of reperfusion (p<0.05). Erythrocyte cata-
lase activity in group 1 rabbits increased and remai-
ned high over all period of ischemia/reperfusion.
By the end of reperfusion, enzyme activity in hepa-
tic venous blood exceeded the basal level by 101.1%
(p<0.05). As distinct from group 1 animals, catalase
activity in NG-receiving rabbits increased only in
erythrocytes of hepatic venous blood (by 43.7% of
the basal level, p<0.05). α-Tocopherol concentra-
tion in the plasma of various blood samples did not
exceed the basal level (Table 1).
The intensity of LPO and activity of the anti-
oxidant system were studied in the liver homo-
genate. After 120-min reperfusion, CD concentra-
tion in group 1 animals increased from 4.97±0.54
TABLE 1. Effect of NG on the Prooxidant-Antioxidant Balance in the Blood during Liver Ischemia/Reperfusion (M±m)
Hepatic venous blood
plasma CD, ΔE
233
/ml 0.58±0.05 1.13±0.14* 2.13±0.10* 0.51±0.04 0.59±0.04+ 0.81±0.09*+
SB, U/ml 8.49±0.42 12.75±0.58* 14.35±0.47* 8.89±0.28 10.71±0.49*+ 9.38±0.23+
αtocopherol, μmol/liter 20.80±0.58 19.34±0.24* 16.54±0.26* 20.45±0.43 19.19±0.35* 19.33±0.38+
erythrocytes
catalase, mmol/liter/g
hemoglobin 2.77±0.31 3.81±0.33* 5.57±0.06* 2.03±0.17 2.43±0.25+ 2.92±0.27*+
Mixed venous blood
plasma CD, ΔE
233
/ml 0.57±0.05 1.56±0.31* 2.58±0.55* 0.63±0.05 1.08±0.18* 1.03±0.20+
SB, U/ml 9.47±0.12 11.65±0.59* 12.86±0.28* 9.19±0.37 12.06±0.67* 9.95±0.32+
αtocopherol, μmol/liter 21.25±0.48 18.56±0.43* 16.02±0.28* 20.12±0.40 18.91±0.29* 19.11±0.30+
erythrocytes
catalase, mmol/liter/g
hemoglobin 2.50±0.33 3.82±0.37* 6.18±0.02* 2.01±0.15 2.53±0.20+ 2.61±0.32+
Note. Here and in Table 2: p<0.05: *compared to the basal level; +compared to another group in the same period.
Parameter 120th
minute of
reperfusion
30th
minute of
ischemia
basal level
Group 2Group 1
120th
minute of
reperfusion
30th
minute of
ischemia
basal level
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to 11.42±1.04 ΔE233/g (p<0.01). SB concentration
increased from 120.30±12.47 to 404.6±50.2 U/g
(p<0.001). α-Tocopherol concentration decreased
from 19.77±0.68 to 12.17±0.26 nmol/100 mg
(p<0.001). Catalase activity in the liver homogenate
increased from 8.36±0.56 to 11.45±0.35 mmol/g
protein/sec (p<0.01). By the 120th minute of reper-
fusion, the test parameters of the prooxidant/anti-
oxidant balance in group 2 rabbits did not differ
from the control.
Ischemia/reperfusion in group 1 rabbits was
accompanied by an increase in ALT and AST acti-
vities in the blood after reperfusion. It should be
noted that enzyme activities remained unchanged
by the end of ischemia (Table 2). Activities of ALT
and AST in the plasma of mixed venous blood in-
creased by 161.3 and 184.8%, respectively, after
120-min reperfusion (p<0.05). The increase in acti-
vities of these enzymes in blood plasma reflects
impairment of hepatocyte membrane integrity du-
ring ischemia/reperfusion. Activities of ALT and
AST in the plasma of hepatic and mixed venous
blood from group 2 animals remained practically
unchanged during hepatic ischemia/reperfusion.
The total concentration of nitrites and nitrates in the
plasma of hepatic and mixed venous blood from
NG-treated rabbits increased by the 30th minute of
ischemia (by 70.4 and 45.4% of the basal level,
respectively, p<0.05). However, by the end of re-
perfusion the total concentration of nitrites and
nitrates in the plasma of hepatic and mixed venous
blood from these animals exceeded the basal level
by only 18.3 (p>0.05) and 23%, respectively (Ta-
bles 1 and 2). The total concentration of nitrites and
nitrates remained unchanged in group 1 animals
with hepatic ischemia/reperfusion.
Accumulation of CD and SB in the blood and
liver tissue reflects a significant increase in LPO
intensity, which is accompanied by a decrease in
activity of the antioxidant defense system. These
changes contribute to a shift in the prooxidant-
antioxidant balance toward activation of free radi-
cal processes. The observed changes probably cause
liver dysfunction by the end of reperfusion (in-
crease in ALT and AST activities). It should be
emphasized that some parameters of LPO and anti-
oxidant system were stabilized in group 2 animals,
particularly in mixed venous blood and liver tissue.
Our results indicate that NG infusion improves liver
function after ischemia. These changes were obser-
ved against the background of increased total level
of nitrites and nitrates and were probably related to
an increase in the concentration of NO and restora-
tion of the balance between vasoconstrictors and
vasodilators in the liver during the postischemic
period, which improves hepatic microcirculation. It
should be noted that NG infusion could improve
function of other organs, first of all, of the lungs
and heart. Liver reperfusion is often accompanied
by damage to these organs [7,9]. The involvement
of the L-arginine-NO system (e.g., NG) in the mainte-
nance of the prooxidant-antioxidant balance is me-
diated by several mechanisms. NO may contribute
to antioxidant protection. NO has function of a
radical-trapping compound and modifies O2-bin-
ding properties of the blood. It is necessary to take
into account that the pathogenesis of hepatic reper-
fusion injury is mediated by the O2-dependent me-
chanism [10].
The data indicate that NG improves the pro-
oxidant-antioxidant balance and liver function in
rabbits during ischemia/reperfusion.
TABLE 2. Effect of NG on Total Concentration of Nitrites and Nitrates and Functional State of the Liver during Ischemia/
Reperfusion (M±m)
Hepatic venous blood
ALT, μmol/liter/min 4.81±0.21 5.08±0.16 9.41±0.52* 4.00±0.35 4.32±0.33 4.81±0.27+
AST, μmol/liter/min 3.52±0.19 3.93±0.16 6.85±0.82* 3.84±0.40 4.07±0.29 4.47±0.32+
Nitrates and nitrites 5.89±0.89 6.88±0.89 6.23±0.83 4.15±0.65 7.04±0.61* 4.91±0.65
Mixed venous blood
ALT, μmol/liter/min 4.48±0.24 4.82±0.21 11.74±1.16* 4.11±0.34 4.25±0.37 4.97±0.47+
AST, μmol/liter/min 3.94±0.37 4.70±0.27 11.25±1.18* 3.78±0.52 4.39±0.30 5.22±0.51+
Nitrates and nitrites 5.19±0.63 5.54±1.00 5.71±0.77 4.83±0.55 7.02±0.77*+ 5.94±0.64
Parameter 120th
minute of
reperfusion
30th
minute of
ischemia
basal level
Group 2Group 1
120th
minute of
reperfusion
30th
minute of
ischemia
basal level
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